Introduction {#sec1-1}
============

Intensity-modulated radiation therapy (IMRT) is the delivery of radiation dose to the patient through fields that have nonuniform radiation fluence.\[[@ref1]\] Introduction of IMRT creates the possibility of generating dramatically improved dose distributions that could be tailored to fit complex shapes. The IMRT is a promising treatment technique having advantage of delivering highly conformal dose distribution to the target volume and sparing of organs at risk.\[[@ref2]\] However, stringent quality assurance program is required to be instituted in dose calculation, dose delivery, and measurement system for effective and safe clinical implementation of this technique.\[[@ref3]\]

There are many advantages of IMRT over three-dimensional radiotherapy.\[[@ref3][@ref4]\] IMRT technique can be done by the use of a static multileaf collimator (MLC) and a dynamic MLC technique.\[[@ref5]\] Task Group-119 (TG-119) IMRT commissioning tests of The American Association of Physicists in Medicine (AAPM) have been given to check precision of IMRT. It has four levels of computed tomography (CT) scan with structures named multitarget, mock prostate, mock head and neck, and C-shape. The first object of these test cases was to be able to check the whole precision of IMRT commissioning. These test cases were implemented to check the efficiency of the targeted image-guided radiation therapy (TiGRT) treatment planning system (TPS). Initial check was done to remove the effect of daily output variation of the linear accelerator.\[[@ref5][@ref6]\] The beam design for planning, given dose, specific plan evaluation, and measurement of dose delivery techniques were explained in AAPM TG-119.\[[@ref5][@ref6][@ref7]\] Recently, researchers have done TG-119 protocol on different planning systems, different detectors, and LINAC machines with different photon energies and obtained different gamma criteria.\[[@ref8][@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16]\]

According to the author\'s best knowledge, there is a lack of commissioning studies verifying TPS and delivered accurate dose in IMRT using TiGRT TPS for 6 MV photon energy LINAC. Furthermore, there is no report on the application of TG-119 test on TiGRT TPS with Primus accelerator machine and TiGRT dynamic MLC (DMLC) system. In this work, TG-119 test on TiGRT TPS was done with Primus accelerator system and TiGRT DMLC. This study aimed to evaluate the overall accuracy of the beam commissioning criteria of TiGRT TPS based on the TG-119 guidelines.

Materials and Methods {#sec1-2}
=====================

This work was performed using 6 MV photon beam energy linear accelerator (Siemens Primus, USA) and the variable dose rate of 200 MU/min. It was equipped with high-quality external TiGRT DMLC H with 51 pairs of MLCs with 0.6 and 0.36 cm resolution in isocenter. The maximum length of field size is 32 cm and the MLC leaf length is 26.54 cm. In this MLC, maximum over travel from the center is 12.8 cm and minimum gap between leaf pairs is 0.19 cm. The major leaf speed is 2.97 cm/s. The phantom was water-equivalent plastic phantom with a density of 1.03 g/cm^3^ and dimensions of 30 cm × 30 cm × 15 cm that is typically squares or rectangles. This phantom has a suitable thickness to put the ionization chamber at its center for the aim of dosimetric measurements. Another advantage of this phantom is permitting planar dose measurement (kinds of film) to be done on coronal planes. CT images of this phantom were obtained and then imported in the TPS. During CT scan, some markers were put in the phantom for performing the best contouring and also some points were defined to calculate dose in the TPS. TiGRT TPS was calculated with the full scatter convolution algorithm. The system is able to carry conformal and IMRT techniques. The system is able to perform forward and reverse calculations. TiGRT TPS supports step and shoot and sliding IMRT technique. Pinpoint chamber (PTW, Freiburg, Germany, model 31014) with the effective or sensitive volume of 0.015 cm^3^ was used to point dose measurements.

The AAPM TG-119 IMRT commissioning tests are composed of two preliminary tests and four clinical test cases.\[[@ref5]\] The preliminary tests are about the evaluation of the precision dose calculation, and clinical tests consist of test prostate, head and neck, C-shaped target, and multitarget\[[@ref5]\] which are shown in [Figure 1](#F1){ref-type="fig"}. The test cases were done with a CT scanner (Siemens SOMATOM EMOTION, Germany) and imported into the TiGRT TPS.

![Two-dimensional view of test structure sets: (a) Multitarget, (b) prostate, (c) head and neck and (d) C-shape](JMSS-8-95-g001){#F1}

[Figure 1](#F1){ref-type="fig"} shows two-dimensional (2D) view of test structure sets which are described as follow: [Figure 1a](#F1){ref-type="fig"} demonstrates three cylindrical targets named multitarget cases, which were drawn along the axis of rotation, each having a diameter of 4.0 cm and length of 4.0 cm and including central target, superior target, and inferior target. [Figure 1b](#F1){ref-type="fig"} shows the mock prostate case including the prostate, planning target volume (PTV), rectum, and bladder. The rectum was a cylinder with a diameter of 1.5 cm. One-third of the rectum volume was inside the PTV of the prostate. The bladder was roughly ellipsoidal and was centered on the superior portion of the prostate. The prostate clinical target volume (CTV) is roughly ellipsoidal with right lateral (RL), anterior-posterior (AP), and superior interior (SI) dimensions of 4.0, 2.6, and 6.5 cm, respectively. The prostate PTV is expanded to 0.6 cm around the CTV. The rectum is a cylinder with a diameter of 1.5 cm that abuts the indented posterior aspect of the prostate. The PTV includes about one-third of the rectal volume on the widest PTV slice. The bladder is roughly ellipsoidal with RL, AP, and SI dimensions of 5.0, 4.0, and 5.0 cm, respectively, and is centered on the superior aspect of the prostate.

[Figure 1c](#F1){ref-type="fig"} illustrated the mock head and neck case including the PTV, spinal cord, right parotid, and left parotid. The PTV is retracted from the skin by 0.6 cm. There is a gap of about 1.5 cm between the cord and the PTV.

[Figure 1d](#F1){ref-type="fig"} shows the C-shape case including a C-shape target that surrounded a central isolation structure called core. The center core is a cylinder with 1 cm in radius. The interval between the core and the PTV is 0.5 cm; therefore, the interior curve of the PTV is 1.5 cm in radius. The outer curve of the PTV is 3.7 cm in radius. The PTV and core are 8 and 10 cm long, respectively. The frontal view of the treatment planning software is shown in [Figure 2](#F2){ref-type="fig"}.

![The frontal view of the treatment planning algorithms](JMSS-8-95-g002){#F2}

According to AAPM TG-119, each experiment was done with film to be placed in at least on coronal plane and to be exposed to all fields of the phantom with the planned collimator and gantry angles.\[[@ref9]\] The entire center tries to gain the best result for film dosimetry.\[[@ref10]\] Dose distributions were analyzed applying gamma criteria of 3% and 2% DD and 3 and 2 mm distance to agreement (DTA). The planar dose distributions obtained with the film could be normalized to the dose measured with the chamber at an appropriate point in a high-dose and low-gradient region.

EDR2 (Kodack, Japan) film has appropriate spatial resolution and is independent of beam angle, energy, and dose rate.\[[@ref11]\] Film dosimeters have some advantages for being 2D detectors that give permanent records of the measuring dose distribution at high resolutions.\[[@ref11][@ref12]\]

EDR2 film is a very slow speed and fine-grain film. Double emulsion active layers, formed by very fine monodispersed cubic microcrystals, are coated on a 0.18 mm Easter base, which allows processing of film in a conventional rapid film processor.\[[@ref17]\] The same batch of 10 × 12 inch EDR2 ready pack film and its calibration files were used throughout this study. A Kodak Xomat film processor was used for processing irradiated EDR2 films.\[[@ref12]\]

A calibration data set for EDR2 film type was acquired by placing a film under a 1.5 cm thickness solid water phantom with 20 cm solid water underneath. The dose output to the water from linear accelerator was calibrated using an ion chamber calibrated by the Accredited Dosimetry Calibration Laboratory (ADCL).

Films were irradiated by 6 MV photon beams perpendicular to the beam axis, with a field size of 5 cm × 5 cm. The dose delivered at a given depth was calculated by multiplying the delivered MUs and output factor for 5 cm × 5 cm field size. Care was taken to minimize the contribution of collimator scattered photons reaching the unirradiated region of the film. Fourteen dose points were obtained using four films by irradiating the films with different doses up to 700 cGy. The perpendicular irradiation geometry was chosen for the film calibration because IMRT plans studied would use either coplanar or noncoplanar beam arrangement; therefore, neither perpendicular nor parallel irradiation setup for calibration would be corrected for the direction of film exposure and cannot be corrected by the calibration process. The processed films were scanned, and the region of interest (ROI) of 4 mm × 4 mm was selected at the middle of the irradiated region to get the optical density (OD) measurement. For dose range of 0--700 cGy, EDR2 films responded with a linear response up to 500 cGy in the OD range of 0.20--3.04.\[[@ref12]\]

In this study, as it will be mentioned in the following parts, it is possible to have both film and chamber on the central measurement plane so that the film response can be normalized to the chamber. The used phantom was scanned for planning and measurements goal. The plans were done on the phantom with the structures outlined on it. The chamber measurements were to be made with all fields irradiating the phantom using the planned gantry and collimator angles. For most of the tests, measurements were made in at least two locations, one in the target and another in a low-dose avoidance structure. The doses were expected to be at least 30 cGy, so issues with very low-dose measurements would not arise. Conversion of chamber reading to dose was done by first irradiating the phantom with parallel-opposed 10 cm × 10 cm fields arranged isocentrically and establishing the ratio of reading to planned dose in that geometry. This was done to reduce the effects of daily LINAC output variations and differences between the phantom and liquid water.

Each test called for a film to be placed in at least one coronal plane and to be exposed to all fields irradiating the phantom with the planned gantry and collimator angles. Dose distributions were analyzed using gamma criteria of 3% and 2% DD and 3 and 2 mm DTA. The planar dose distributions obtained with the film could be normalized to the dose measured with the chamber at a suitable point in a high-dose and low-gradient region. The film analysis was done with the SNC patient software (Sun Nuclear Corporation, Melbourne, FL, USA).

Two preliminary tests with simple fields irradiating the phantom were requested to demonstrate the reliability of the assessment system for non-IMRT dose delivery, followed by five tests of IMRT plans with increasing complexity.

Preliminary tests were done on slab phantom. Preliminary tests included two examinations. Test 1 included parallel opposed AP: PA 10 cm × 10 cm fields to deliver 200 cGy at the isocenter. Test 2 included a set of five AP: PA bands of 3 cm using asymmetric jaws, with doses ranging from 40 to 200 cGy which could be done using asymmetric jaws. The central dose was measured with chamber and the dose distribution on the central plane was measured by film.

For test cases, beam arrangements for sliding IMRT were done as mentioned in AAPM TG-119. For multitarget and mock prostate cases, seven static beams were placed at 50° intervals. For mock head and neck and C-shape cases, nine static beams were placed at 40° intervals. All plans were made according to the goal described in TG-119. The isodose and dose--volume histogram were used as the evaluation tool. As per our institutional policy, for patient quality assurance, the plans were transferred to the QA map-check phantom in TiGRT TPS with the original gantry angle and collimator angle at 0° for its verification.

Data analysis {#sec2-1}
-------------

Point doses were measured with the pinpoint (PTW, Freiburg, Germany, model 31014) chamber and compared to point doses calculated by the TPS, which were taken as the mean dose for a 0.125 cm^3^ ROI centered around the mid-chamber position in the planning CT image set. For each point dose, a percentage difference was computed using the following formula:\[[@ref13]\]

![](JMSS-8-95-g003.jpg)

Where *D*~measured~ is the measure dose, *D*~calc~ is the calculated dose, and *D*~prescrip~ is the prescribed dose. EDR2 films measurements were compared to planar doses calculated by the TPS at a dose grid resolution of 2 mm × 2 mm. Measured and calculated planar doses were compared using gamma analysis using a 2% DD and distance to agreement of 2 mm. The analysis was done for 3% and 3 mm as well.

Results {#sec1-3}
=======

For pretest 1, the measured and calculated point dose at isocenter is given in [Table 1](#T1){ref-type="table"}.

###### 

Results of point dose measurement in the phantom for pretest 1

![](JMSS-8-95-g004)

Experimental film dosimetry resulted in passing gamma criteria of 3% DD and 3 mm DTA with accuracy of 97%. Pretest 2 contained a set of five AP: PA bands of 3 cm using asymmetric jaws, with doses ranging from 40 to 200 cGy. [Figure 3](#F3){ref-type="fig"} shows the dose distribution for preliminary tests and [Table 2](#T2){ref-type="table"} shows the results of this measurement.

![Dose distribution for pretest](JMSS-8-95-g005){#F3}

###### 

Results of point dose measurement in the phantom for pretest 2

![](JMSS-8-95-g006)

[Table 3](#T3){ref-type="table"} showed the results for the test cases, multitarget, prostate, head and neck, and C-shape.

###### 

Result of point dose measurement in phantom for multitarget, mock prostate, mock head and neck, and C-shaped

![](JMSS-8-95-g007)

The differences between measured doses by ion chamber and that calculated using TiGRT TPS should be within 3% for whole plan in all location sites (multitarget, mock prostate, mock head and neck, and C-shape). If the result gives a variation higher than 4%, the QA procedure is repeated. [Table 3](#T3){ref-type="table"} shows that 100% of the measurements vary \<3% from calculated dose. This table also shows the difference errors of the percentage at each point dose measurement site.

EDR2 film dosimetry was used to compare the calculated and measured doses. Two separated gamma criteria DD/DTA for the entire location site are compared: 2%/2 mm and 3%/3 mm. The DDs between measured dose (LINAC delivery) and calculated dose (TPS) are evaluated.

As can be seen from [Table 4](#T4){ref-type="table"}, the criteria of 2% DD and 2 mm DTA show that the gamma passed rates are \>90.7%. On the other hand, the criteria of 3% DD and 3 mm DTA showed that gamma passed rates are \>96.9%. The best results were obtained for multitarget location site.

###### 

Results of gamma analysis of all location sites for dynamic intensity-modulated radiation therapy

![](JMSS-8-95-g008)

Discussion {#sec1-4}
==========

Using TG-119 protocol to verify the accuracy of measurements and compliance with the calculation TPS, it will be claimed to use treatment planning software with more confidence in IMRT techniques.

TG-119 protocol was applied to evaluate the accuracy and precision of the TiGRT TPS. TiGRT TPS performs the appropriate and admirable inverse plan for the sliding (dynamic) IMRT.

As shown in [Table 4](#T4){ref-type="table"}, results of this work for multitarget test were acceptable and had more confidence than other studies such as Ezzel *et al*. and Mynampat *et al*.\[[@ref5][@ref7]\]

Comparing sliding IMRT technique with the step and shoot IMRT technique accompanying using the TG-119 criterion showed that the sliding IMRT technique has true measurements and has fewer faults.\[[@ref14][@ref17]\] In this work, small ionization chamber (Pinpoint) was used instead of larger ionization chamber (Farmer) which was used by other researchers.\[[@ref14][@ref15][@ref16]\] The main advantage of this small chamber is its use for increasing the accuracy, in particular, in high-dose gradient and edge of the fields.\[[@ref18]\]

Comparing the results with other relevant studies, film dosimetry can be used instead of 2D arrays. Film has more resolution than the other 2D arrays such as Octavius and Mapcheck2.\[[@ref9]\]

By comparing point of view of planning cost and simplicity with other machines,\[[@ref5][@ref7]\] it is important to notice that Primus LINAC which added on TiGRT DMLC is cheaper than other complex LINAC machines.

The data from this study were more accurate than other studies in some tests such as multitarget.\[[@ref5][@ref7]\] Fortunately, the results of this work regarding the dose point were within the mean values of the range reported by TG-119.\[[@ref5]\]

The main advantage of this study is its clinical application. One of the strengths of this study was using film dosimetry instead of the 2D which has a higher resolution than the 2D arrays.\[[@ref12]\] The result of gamma pass rate is a good reason to use TiGRT TPS for IMRT techniques.

Conclusions {#sec1-5}
===========

Dose distribution was in the range of 99.1% to 93% using gamma criteria of 3% and 2% DD and 3 and 2 mm distance to agreement (3%/3 and 2%/2), respectively overall test cases. Findings of this work were very favorable and in some tests were comparable with other studies. Furthermore, the results of dose point were within the mean values of the range reported by TG-119. Overall, the TiGRT TPS may be suitable for use in IMRT DMLC radiation therapy techniques.
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